share_log

NEXGEL to Participate in the IAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024

NEXGEL to Participate in the IAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024

NEXGEL將參加於2024年12月10-11日舉行的IAccess Alpha虛擬最佳創意冬季會議。
GlobeNewswire ·  11/21 22:00

LANGHORNE, Pa., Nov. 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10 and 11, 2024.

LANGHORNE,賓夕法尼亞州,2024年11月21日(環球新聞社)- NEXGEL公司(「NEXGEL」或「公司」)(納斯達克:「NXGL」),醫療和場外交易(OTC)產品領先供應商,包括用於醫療保健和消費領域的超溫和、高含水量的水凝膠產品,今日宣佈首席執行官亞當·萊維(Adam Levy)將於2024年12月10日和11日在iAccess Alpha虛擬最佳創意冬季峯會上發表演講。

iAccess Alpha Virtual Conference Details:
Date: December 10-11, 2024
Presentation Day and Time: Tuesday, December 10th at 10:30 a.m. ET
Webcast:

iAccess Alpha虛擬會議詳情:
日期:2024年12月10-11日
演示日期和時間:東部時間12月10日星期二上午10:30
網絡直播:

To schedule a one-on-one investor meeting with Mr. Levy, please contact your representatives at iAccess or email KCSA Strategic Communications at NEXGEL@KCSA.Com.

如需安排一對一投資者會議,請聯繫iAccess的代表或發送電子郵件至KCSA戰略通訊處與萊維先生聯繫。 NEXGEL@KCSA.Com.

About NEXGEL, Inc.

關於NEXGEL公司

NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal, Hexagels, Turfguard, Kenkoderm and Silly George. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

NEXGEL是醫療、美容和場外交易(OTC)產品的領先提供商,包括超溫和、高含水量的水凝膠。總部位於賓夕法尼亞州朗霍恩,該公司已經開發和製造電子束交聯水凝膠超過二十年。NEXGEL品牌包括SilverSeal、Hexagels、Turfguard、Kenkoderm和Silly George。此外,NEXGEL與領先的消費者醫療公司建立了戰略性的合同製造關係。

Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
NEXGEL@KCSA.com

投資者聯繫方式:
Valter Pinto, 董事總經理
KCSA戰略傳播
212.896.1254
NEXGEL@KCSA.com


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論